In an interview, Dr. David A. Taub highlighted Prostate Cancer Awareness Month by outlining current treatment options for patients with prostate cancer. In an interview with CURE, Dr. David A. Taub ...

The FDA has expanded its approval of talazoparib in combination with enzalutamide to include men with metastatic androgen ...

Choosing prostate cancer treatment takes more than explaining options. Explore strategies to communicate risks, clarify ...

Xtandi's label as the cancer treatment paradigm shifts towards the use of mutation-specific targeted therapies.

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

A prostate cancer diagnosis rarely comes with one obvious answer. It comes with several reasonable paths that differ in side effects, recovery and long term tradeoffs, and the right one depends on the ...

About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...

Mercy Medical Center was expanding advanced treatment options for men with prostate cancer through the enhanced capabilities of its Varian TrueBeam radiotherapy system, providing appropriately ...

Newswise — (Baltimore, Maryland -Oct. 13th, 2026)-- Mercy Medical Center is expanding advanced treatment options for men with prostate cancer through the enhanced capabilities of its Varian TrueBeam ...